None listed
Conditions
Brief summary
This registry will include patients who present with an abnormality in the wall of their aorta (Type B aortic syndrome) with the aim of determining the natural history and clinical outcomes of this condition. Specifically, the group will look at the outcomes of patients who were treated with early intervention and/or basic medical therapy. From this study, the relationship between patient factors including kidney injury, and benefit from early intervention will be reported.
Interventions
Participants will be recruited from patients who present to Royal North Shore Hospital in Sydney, NSW, and are diagnosed with Type B Aortic Syndrome, whether complicated or uncomplicated. Informed consent will be obtained prior to registration. Data collection for the initial time point (baseline) will be for the duration of the initial hospital stay. This will record inpatient management. Following discharge, patients will be followed up at specific timepoints (1 week, 3 months, 6 months, 12 months and annually thereafter) for the duration of the study (10 years). Patients will present for surveillance imaging prior to their appointment with their consultant vascular surgeon, or with a member of the research team. A quality-of-life questionnaire will also be completed at the same time. Follow up will take approximately 20 to 30 minutes. The registry also aims to include patients who presented from January 2019. After ensuring patient's survival status, written informed consent will be obtained. Follow up data will be collected from the consultant surgeon's private practice and surveillance scans from radiology labs.
Sponsors
Eligibility
Inclusion criteria
Patients over the age 18 presenting at Royal North Shore Hospital, Sydney, NSW, and diagnosed with a type B aortic dissection. They must have given written consent.
Exclusion criteria
Patients who do not wish to participate or give consent.